<DOC>
	<DOCNO>NCT00001749</DOCNO>
	<brief_summary>Diamond Blackfan anemia ( DBA ) condition bone marrow underdevelop . DBA consider congenital disease , mean patient bear . In DBA lack cell give rise red blood cell . The element produce bone marrow , white blood cell platelet , normal . Standard treatment use disorder steroid bone marrow transplant associated failure , relapse , side-effects , increased morbidity , even death . Two drug , antithymocyte globulin ( ATG ) cyclosporin use treat DBA , provide occasional response . No study ever combine two drug treatment DBA . This study design explore combine use ATG cyclosporine rational approach treatment DBA .</brief_summary>
	<brief_title>Medical Treatment Diamond Blackfan Anemia</brief_title>
	<detailed_description>Diamond Blackfan anemia ( DBA ) constitutional pure red cell aplasia unknown etiology . There laboratory evidence immune mechanism patient respond corticosteroid . However relapse failure rate high , corticosteroid associate many short long term side effect . Patients respond tolerate corticosteriods require lifelong red blood cell transfusion iron chelation therapy . Allogeneic bone marrow transplantation option relate histocompatible donor , procedure associate high mortality morbidity . Other therapy try without general success . Occasional response either ATG cyclosporine report , study use ATG cyclosporine . In blood/bone marrow disorder immune etiology drug synergistic effect . We propose Phase II study explore combine use ATG cyclosporine rational approach treatment Diamond Blackfan anemia .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Fanconi Anemia</mesh_term>
	<mesh_term>Fanconi Syndrome</mesh_term>
	<mesh_term>Anemia , Diamond-Blackfan</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>INCLUSION CRITERIA : Diagnosis DBA characterize hyporegenerative anemia present early childhood reticulocytopenia , low absent erythroid precursor bone marrow . Transfusiondependence due steroid failure intolerance steroid side effect . Ineligible decline allogeneic transplant . Ages 3 75 . EXCLUSION CRITERIA : Serum creatinine great 2 time normal creatinine clearance le 50 % normal . SGPT SGOT great 5 time normal . History epilepsy ( seizure besides childhood febrile seizure ) . Current pregnancy unwillingness take oral contraceptive menstruate . Positive diepoxybutane ( DEB ) test Fanconi anemia . HIV positivity . Inability unwillingness sign inform consent , either patient , case minor , parent guardian responsible patient . Underlying organ failure and/or Karnofsky performance status less 1 . Treatment androgen , prednisone great 10 mg/day , growth factor , immunosuppressive therapy within one month protocol entry . Ongoing treatment Betaadrenergic block drug . Previous treatment ATG concurrent CSA . Previous treatment either drug alone acceptable great one year prior study entry .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>Immune Suppression</keyword>
	<keyword>Erythroid Hypoplasia</keyword>
	<keyword>Congenital Anemia</keyword>
	<keyword>Reticulocytopenia</keyword>
	<keyword>Diamond Blackfan Anemia</keyword>
</DOC>